Adi Zundelevich

6 Weizmann Street
Tel Aviv, TA 64239, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer Treatment.

Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer Treatment.

Journal: Journal of personalized medicine

Published: March 30, 2026

Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.

Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.

Journal: Cells

Published: July 26, 2024

Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-rich Cannabis sativa strains.

Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-rich Cannabis sativa strains.

Journal: Asian journal of urology

Published: June 03, 2024

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.

Journal: Frontiers in medicine

Published: May 12, 2023

Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.

Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.

Journal: Biomedicines

Published: July 27, 2022

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Journal: Cancer discovery

Published: April 19, 2022

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.

Journal: Breast cancer research : BCR

Published: March 14, 2020

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.

Journal: Science translational medicine

Published: December 05, 2019

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.

Journal: Breast cancer research : BCR

Published: September 01, 2019

Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.

Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.

Journal: Neoplasia (New York, N.Y.)

Published: June 17, 2015

Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemness.

Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemness.

Journal: Cellular reprogramming

Published: July 12, 2013

Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues.

Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues.

Journal: Nature genetics

Published: March 15, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026